OLMESART AMLO HCT 40/5/25 olmesartan medoxomil/amlodipine (as besilate) and hydrochlorothiazide 40 mg/5 mg/25 mg tablet blister pack Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

olmesart amlo hct 40/5/25 olmesartan medoxomil/amlodipine (as besilate) and hydrochlorothiazide 40 mg/5 mg/25 mg tablet blister pack

arrotex pharmaceuticals pty ltd - olmesartan medoxomil, quantity: 40 mg; hydrochlorothiazide, quantity: 25 mg; amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; magnesium stearate; colloidal anhydrous silica; croscarmellose sodium; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - it is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination.this fixed dose combination is not indicated for initial therapy.

OLMESART AMLO HCT olmesartan medoxomil/amlodipine (as besilate) and hydrochlorothiazide 40 mg/5 mg/12.5 mg tablet blister pack Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

olmesart amlo hct olmesartan medoxomil/amlodipine (as besilate) and hydrochlorothiazide 40 mg/5 mg/12.5 mg tablet blister pack

arrotex pharmaceuticals pty ltd - olmesartan medoxomil, quantity: 40 mg; hydrochlorothiazide, quantity: 12.5 mg; amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; pregelatinised maize starch; colloidal anhydrous silica; croscarmellose sodium; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - it is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination.this fixed dose combination is not indicated for initial therapy.

OLMESART AMLO HCT 20/5/12.5 olmesartan medoxomil/amlodipine (as besilate) and hydrochlorothiazide 20 mg/5 mg/12.5 mg tablet blister pack Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

olmesart amlo hct 20/5/12.5 olmesartan medoxomil/amlodipine (as besilate) and hydrochlorothiazide 20 mg/5 mg/12.5 mg tablet blister pack

arrotex pharmaceuticals pty ltd - hydrochlorothiazide, quantity: 12.5 mg; amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg); olmesartan medoxomil, quantity: 20 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; magnesium stearate; croscarmellose sodium; colloidal anhydrous silica; microcrystalline cellulose; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - it is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination.this fixed dose combination is not indicated for initial therapy.

OLMESARTAN AMLO HCT GPPL 40/5/12.5 olmesartan medoxomil/amlodipine (as besilate) and hydrochlorothiazide 40 mg/5 mg/12.5 mg tablet blister pack Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

olmesartan amlo hct gppl 40/5/12.5 olmesartan medoxomil/amlodipine (as besilate) and hydrochlorothiazide 40 mg/5 mg/12.5 mg tablet blister pack

arrotex pharmaceuticals pty ltd - olmesartan medoxomil, quantity: 40 mg; hydrochlorothiazide, quantity: 12.5 mg; amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; pregelatinised maize starch; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - it is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination.this fixed dose combination is not indicated for initial therapy.

Amlodipine Besilate Viatris 5 mg tabl. Belġju - Ingliż - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

amlodipine besilate viatris 5 mg tabl.

viatris gx bv-srl - amlodipine besilate 6,94 mg - eq. amlodipine 5 mg - tablet - 5 mg - amlodipine besilate - amlodipine

Amlodipine Besilate Viatris 10 mg tabl. Belġju - Ingliż - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

amlodipine besilate viatris 10 mg tabl.

viatris gx bv-srl - amlodipine besilate 13,88 mg - eq. amlodipine 10 mg - tablet - 10 mg - amlodipine besilate - amlodipine

APO-OLMESARTAN/AMLODIPINE/HCTZ 40/10/12.5 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/10/12.5 mg film-coated tablet blister pack Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

apo-olmesartan/amlodipine/hctz 40/10/12.5 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/10/12.5 mg film-coated tablet blister pack

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.9 mg; hydrochlorothiazide, quantity: 12.5 mg; olmesartan medoxomil, quantity: 40 mg - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; povidone; pregelatinised maize starch; silicified microcrystalline cellulose; isopropyl alcohol; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - apo-olmesartan/amlodipine/hctz 40/10/12.5 mg is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination. this fixed dose combination is not indicated for initial therapy.

APO-OLMESARTAN/AMLODIPINE/HCTZ 40/10/25 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/10/25 mg film-coated tablet blister pack Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

apo-olmesartan/amlodipine/hctz 40/10/25 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/10/25 mg film-coated tablet blister pack

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.9 mg; hydrochlorothiazide, quantity: 25 mg; olmesartan medoxomil, quantity: 40 mg - tablet, film coated - excipient ingredients: isopropyl alcohol; silicified microcrystalline cellulose; povidone; lactose monohydrate; pregelatinised maize starch; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - apo-olmesartan/amlodipine/hctz 40/10/25 mg is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination. this fixed dose combination is not indicated for initial therapy.

APO-Perindopril Arginine/Amlodipine 5/5 perindopril arginine 5 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

apo-perindopril arginine/amlodipine 5/5 perindopril arginine 5 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: colloidal anhydrous silica; croscarmellose sodium; microcrystalline cellulose; magnesium stearate - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

APO-Perindopril Arginine/Amlodipine 5/10 perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet bottle Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

apo-perindopril arginine/amlodipine 5/10 perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: colloidal anhydrous silica; croscarmellose sodium; microcrystalline cellulose; magnesium stearate - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.